Millendo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MLND and buy or sell other stocks, ETFs, and their options commission-free!About MLND
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
CEOStephen R. Brady
CEOStephen R. Brady
Employees25
Employees25
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees25
Employees25
MLND Key Statistics
Market cap14.54M
Market cap14.54M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume46.69K
Average volume46.69K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$47.45
52 Week high$47.45
52 Week low$5.35
52 Week low$5.35
People also own
Based on the portfolios of people who own MLND. This list is generated using Robinhood data, and it’s not a recommendation.